Resumption of motor vehicle operation in vasovagal fainters

American Journal of Cardiology

Volumn 83, Issue 4, 1999, Pages 604-606

  Lurie, Keith G ^a   Iskos, Demosthenes ^a   Sakaguchi, Scott ^a   Fahy, Gerard J ^a   Benditt, David G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DISOPYRAMIDE; ERGOT ALKALOID; FLUDROCORTISONE; MIDODRINE; SCOPOLAMINE; SERTRALINE;

ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BODY POSTURE; CLINICAL PRACTICE; DECISION MAKING; DRIVING ABILITY; MEDICAL SOCIETY; PATIENT COUNSELING; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYNCOPE; TILT TABLE TEST; TRAFFIC ACCIDENT; UNITED STATES;

ATTITUDE OF HEALTH PERSONNEL; AUTOMOBILE DRIVING; HEALTH CARE SURVEYS; HUMANS; SYNCOPE, VASOVAGAL; TILT-TABLE TEST;

EID: 0033557544     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00924-2     Document Type: Article

References (15)

1. Epstein AE, Miles WM, Benditt DG, Camm AJ, Darling EJ, Friedman PL, Garson A, Harvey JC, Kidwell GA, Klein GJ, et al. Personal and public safety issues related to arrhythmias that may affect consciousness: implications for regulation and physician recommendations. Circulation 1996;94:1147-1166.
2. Natale A, Sra J, Dhala A, Wase A, Jazayeri M, Deshpande S, Blanck Z, Akhtar M. Efficacy of different treatment strategies for neurocardiogenic syncope. PACE 1995;18:655-662.
3. Milstein S, Buetikofer J, Dunnigan A, Benditt DG, Gornick C, Reyes WJ. Usefulness of disopyramide for prevention of upright tilt-induced hypotensionbradycardia. Am J Cardiol 1990;65:1339-1344.
4. Morillo CA, Leitch JW, Yee R, Klein GJ. A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J Am Coll Cardiol 1993;22:1843-1848.
5. Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliott L. Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. PACE 1993;16:458-464.
6. Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D. A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am J Cardiol 1992;70:339-342.
7. Moya A, Permanyer-Miralda G, Sagrista-Sauleda J, Carne X, Rius T, Mont L, Soler-Soler J. Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 1995;25:65-69.
8. Anonymous. Assessment of the cardiac patient for fitness to drive: 1996 update. Can J Cardiol 1996;12:1164-1170,1175-1182.
9. Grattan E, Jeffcoate GO. Medical factors and road accidents. BMJ 1968;1:75-79.
10. Epstein SE, Quyyumi AA, Bonow RO. Sounding board. Sudden cardiac death without warning: possible mechanisms and implications for screening asymptomatic populations. N Engl J Med 1989;321:320-324.
11. Hossack DW. Death at the wheel: a consideration of cardiovascular disease as a contributory factor to road accidents. Med J Aust 1974;1:164-166.
12. Strickberger SA, Cantillon CO, Friedman PL. When should patients with lethal ventricular arrhythmia resume driving? An analysis of state regulations and physician practices. Ann Intern Med 1991;115:560-563.
13. Larsen GC, Stupey MR, Walance CG, Griffith KK, Cutler JE, Kron J, McAnuty JH. Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia: implications for driving restrictions. JAMA 1994;271:1335-1339.
14. Cambre S, Silverman ME. Is it safe to drive with an automatic implantable cardioverter-defibrillator or a history of recurrent symptomatic ventricular arrhythmias? Heart Dis Stroke 1993;2:179-181.
15. Kou WH, Calkins H, Lewis RR, Boiling SE, Kirsch MM, Langberg JJ, de Buitleir M, Sousa J, El-Atassi R, Morady F. Incidence of loss of consciousness during automatic implantable cardioverter-defibrillator shocks. Ann Intern Med 1991;115:942-945.